Nabsys, a Providence, RI-based high-definition genome mapping company, closed a $21m equity funding.
The round was led by Hitachi High-Technologies Corporation.
The company intends to use the funds to finalize product development and support global commercial launch of their HD-Mapping™ whole-genome electronic mapping platform.
Led by Barrett Bready, M.D., Founder and CEO, Nabsys provides high-definition electronic genome mapping solutions. The company uses proprietary electronic nanochannel detectors to analyze long DNA molecules at high velocity. Its electronic mapping enables routine, scalable analysis of genomic structural variation.
HD-Mapping has applications in a wide variety of key research applications, including de novo assembly, structural variant analysis, metagenome characterization, and strain identification, as well as in next-generation cytogenetics.
FInSMEs
03/10/2019